Global Blood Group Typing Market: Snapshot
The global blood group typing market is prophesied to gain impetus from the increasing number of applications in various types of tests. As noted by experienced analysts, antibody screening could draw a greater growth in the market due to the intensifying demand for the early diagnosis of diseases and swelling prevalence of chronic diseases. Likewise, there could be certain techniques such as polymerase chain reaction (PCR)-based and microarray expected to significantly improve the demand for blood group typing. Having that mentioned, the authors of the report foresee more factors that could up the growth of the market in the near future.
North America Lays Groundwork to Dominate with Stunning Forecast Revenue
The international blood group typing market is envisioned to be segregated into developed and developing regions, where North America could top the list of attractive geographies for revenue growth. By the completion of the forecast period, North America is anticipated to collect a revenue of US$0.8 bn, although its CAGR could be lower than that of few other regions in the market.
Europe is predicted to grow at a CAGR of 6.7% and offer lucrative prospects for companies operating in the international blood group typing market. With a 22.4% share achieved in 2017 up its sleeve, Asia Pacific except Japan (APEJ) could be another attractive region for players to capitalize on the opportunities offered. Japan, on the other hand, could lose 59 basis points (BPS) between 2017 and 2022 and account for a smaller share in the market. The Middle East and Africa (MEA) is expected to be no different than Japan in terms of revenue growth. It could reach an only US$0.08 bn by 2022 end.
Request for the Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=32999
The worldwide blood group typing market could be marked by leading companies such as Bio-Rad Laboratories, Inc., Merck Millipore, Ortho Clinical Diagnostics, Inc., Danaher Corporation, Grifols, S.A., Immucor, Inc., Quotient, Ltd., Bag Health Care GmbH, and Agena Bioscience, Inc.